Related content

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study

By Kobayashi Hirohito   Tanaka Yoshimasa   Yagi Junji   Osaka Yukinari   Nakazawa Hayakazu   Uchiyama Takehiko   Minato Nagahiro   Toma Hiroshi  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 469-476

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

By Waeckerle-Men Ying   Uetz-von Allmen Edith   Fopp Markus   Moos Roger   Böhme Christel   Schmid Hans-Peter   Ackermann Daniel   Cerny Thomas   Ludewig Burkhard   Groettrup Marcus   Gillessen Silke  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1524-1533

Springer Publishing Company

Access to resources Recommend Favorite

Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy

By Bazhin Alexandr   Shevchenko Ivan   Umansky Viktor   Werner Jens   Karakhanova Svetlana  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 1, 2014-01 ,pp. : 59-65

Springer Publishing Company

Access to resources Recommend Favorite

Hypoxia-mediated immune evasion of pancreatic carcinoma cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3666-3672

Spandidos Publications

Access to resources Recommend Favorite

Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 2, 2014-02 ,pp. : 211-222

Bentham Science Publishers

Access to resources Recommend Favorite